-transparent.png){kind=logo}
2.5 mg/day indapamide was administered to 16 hypertensive patients for 30 days. These was a gradual, significant reduction in systolic and diastolic pressure values with no significant changes in plasma and urinary electrolytes. The effect of the drug on ARP and renal performance was also examined. There were no alterations of other metabolic parameters. These data point to a safe and lasting hpotensive action on the part of indapamide.
Related Publications
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
May 1983,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1989,
Indian journal of physiology and pharmacology,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1977,
Current medical research and opinion,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1983,
Current medical research and opinion,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1986,
Current medical research and opinion,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1978,
Bollettino della Societa italiana di cardiologia,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
November 1977,
Minerva medica,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
February 1984,
The Medical letter on drugs and therapeutics,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1981,
Postgraduate medical journal,
G Gragnoli, and
F Puccetti, and
R Nami, and
I Tanganelli, and
R Favilli, and
E Betti
January 1981,
Postgraduate medical journal,
